U.S. House Speaker Nancy Pelosi waits to speak near a memorial for people who have died as a result of COVID-19 on the National Mall in Washington, D.C., Tuesday. (Alex Edelman/AFP/Getty Images)
Canada’s top doctor warns of sharp rise in COVID-19 cases if Canadians don’t follow guidelines
Canada is at a crossroads in its pandemic battle, and the actions of individual Canadians will decide whether there’s a massive spike in COVID-19 cases coming, according to the latest projections from the Public Health Agency of Canada (PHAC). Federal health officials presented new modelling Tuesday that shows the epidemic is accelerating nationally. They warned that if Canadians don’t step up preventative measures, the virus could spread out of control and trigger a wave of infections bigger than the first one.
“With minimal controls, the virus is capable of surging into a very sharp and intense peak because most Canadians don’t have immunity to the virus,” Chief Public Health Officer Theresa Tam told a news conference in Ottawa. Short-term projections show there could be up to 155,795 cases and up to 9,300 deaths by Oct. 3. If the current rate of infection is maintained, the epidemic is expected to resurge — but if that rate increases, it is expected to resurge “faster and stronger,” she said.
Rapid detection of new cases and a swift response to outbreaks are both key to controlling the pandemic, PHAC modelling documents show. Tam said there has been a significant demographic shift in the caseload since June: instead of the virus disproportionately affecting elderly Canadians, most infections are now being reported in Canadians aged 20 to 39.
The last modelling figures were released on Aug. 14. At that time, Canada’s public health officials said they were striving for a best-case scenario but preparing for the worst: a so-called “fall peak” of COVID-19 cases across Canada that would threaten to overwhelm the public health-care system.
The recent rise in cases coincides with the flu and cold season, which could put added strain on hospitals and other health resources. Health-care workers have been working on the front lines for months now and are bracing for a possible spike in hospitalizations, prompting concerns about potential burnout.
Click below to watch more from The National
As cases of COVID-19 rise, there are growing fears that more needs to be done to protect seniors in long-term care homes — places especially hard-hit during the first part of the pandemic. 1:59
IN BRIEF
Federal Conservatives make use of a COVID-19 test not sanctioned by Health Canada
The Ontario caucus of the federal Conservative Party made use of a COVID-19 serological test that has not yet been approved by Health Canada, according to Conservative MP Scot Davidson. Davidson, the Ontario caucus chair, said the caucus used the device “for safety” prior to a recent caucus retreat.
COVID-19 cases are rising sharply in parts of the country, including Ontario, and party leader Erin O’Toole, his wife and at least one of his staffers have all tested positive for the virus. O’Toole’s wife, Rebecca, received a positive test result late Monday after developing symptoms over the weekend.
A spokesperson for O’Toole said the Ontario caucus invited a Canadian company that is seeking approvals from Health Canada to distribute its serological test to appear at its regional meeting. Interested MPs were given the chance to take the test after they were shown a presentation by the company promoting the testing device, she said. The spokesperson said the test already has received approvals from the U.S. Food and Drug Administration.
The tests — which use a blood sample from a finger prick — usually are reserved for people looking to learn whether they’ve been infected by coronavirus at some point in the past. The FDA warns that these kinds of tests can’t “diagnose active coronavirus infection at the time of the test or show that you do not have COVID-19.”
Canada nails down 5th deal for potential COVID-19 vaccine
Canada has now committed more than $1 billion to buy doses of COVID-19 vaccines after securing a fifth deal with Sanofi and GlaxoSmithKline Tuesday. Procurement Minister Anita Anand said Tuesday that Canada has a deal in place to buy up to 72 million doses of their experimental vaccine candidate, which is just starting the second of three trial phases this month.
In all, Canada has committed $1 billion to buy at least 154 million doses of vaccines from five different companies, and most of that money will not be refunded even if the vaccines never get approved. “We need to make a substantial investment in order to ensure that Canada is well positioned to secure access to the successful vaccine or vaccines,” Anand said in an interview with The Canadian Press. “The way in which we are doing that is to bet on multiple horses at the same time in order to ensure that as one or more of those horses crosses the finish line we have access to those vaccines.”
Canada has signed deals with Moderna, Pfizer, Novavax, Johnson & Johnson and now Sanofi and GlaxoSmithKline, all of which are among some of the most promising vaccines, but none of which have completed all the required clinical trials, or been approved for use in Canada.
Anand said Canada has also signed an agreement with Gilead Sciences and McKesson Canada to get 150,000 vials of remdesivir, the only antiviral drug that has proven effective at treating patients with COVID-19. Health Canada approved the drug for use on COVID-19 patients at the end of July. The doses will begin arriving at Canadian hospitals this month.
COVID-19 limits possibilities for former prime minister John Turner’s state funeral
Typically, a former prime minister would be honoured with a public observance of the highest dignity and pomp. But the prospect of spreading COVID-19 will curtail the possibilities for Turner, as it has for many others who have died during the pandemic. The Turner family’s spokesperson, Marc Kealey, said Tuesday the family is still discussing with government officials the date of the funeral and how many people will attend in person.
Canadian Heritage spokesperson Amelie Desmarais said all decisions regarding funeral arrangements will be made in accordance with the family’s wishes and following advice from public health authorities. She said Canadians can send their condolences to the family by signing an online book of condolences or by sending their thoughts privately.
COVID-19 antibody testing finds ‘significant’ number of cases in Vancouver’s Downtown Eastside
Since the earliest days of the COVID-19 pandemic, there has been a heightened level of concern for what might happen to residents of Vancouver’s Downtown Eastside if the neighbourhood was exposed to an outbreak of the disease. Many residents of the community live with limited resources, and poverty, drug use and other issues have left a trail of underlying health conditions.
Yet, while more than 8,200 British Columbians — nearly 3,000 of them within the Vancouver Coastal Health region — have tested positive for the virus, the Downtown Eastside appears to have avoided a major outbreak. But it’s now clear that the neighbourhood hasn’t been spared, according to the Vancouver Infectious Disease Centre (VIDC) — an independent non-profit that provides clinical services, research and outreach on infectious diseases in the Downtown Eastside.
Bloodwork from residents taken by the VIDC and sent to the B.C. Centre for Disease Control for testing indicates that many have had the disease, VIDC medical director Dr. Brian Conway said. “Our preliminary results suggest that a significant number of residents of the Downtown Eastside carry antibodies to COVID-19, indicating that they were infected at some point,” Conway said.
Of the few hundred residents Conway’s team tested, a couple of dozen have the antibodies, he said. There appears to be high levels of infection, at least in shelter environments where there is limited ability to maintain physical distancing, he said. Conway’s work is progressing to the contact tracing phase on Tuesday, as he and his team begin to meet with some of the people who tested positive to try to determine how they experienced the disease, when they had it, where they were, and to whom they might have transmitted COVID-19.
AND FINALLY…
NFL issues more than $1M US in fines to teams, coaches who didn’t wear masks during games
Head coach Andy Reid of the Kansas City Chiefs wears a face shield as he looks on from the sidelines during a game in Inglewood, Calif., Sunday. (Harry How/Getty Images)
NFL coaches thumbed their collective, and exposed, noses at the NFL’s mask mandate in Week 2 of the season. The league responded with hefty fines of $100,000 US per coach and $250,000 per club. The first three to get fined were Denver’s Vic Fangio, San Francisco’s Kyle Shanahan and Seattle’s Pete Carroll, according to a person with knowledge of the punishment who spoke to The Associated Press on condition of anonymity because the coaches were not identified.
The punishment was meted out a week after the NFL reminded team personnel on the sidelines about the rules for wearing face coverings during the coronavirus pandemic, lest they put the fledgling season at risk. More coaches and clubs can expect similar punishments as the memo last week from Troy Vincent, who oversees the league’s football operations, was largely ignored throughout the weekend, with multiple offenders from coast to coast.
In his strongly worded memo, Vincent said teams “must remain vigilant and disciplined in following the processes and protocols put in place by not only the league, union and clubs, but also by state and local governments.” The rules don’t apply to players, but all other individuals with bench area access, including coaches and members of the club medical staff, are required to wear face coverings at all times.
TORONTO – Restaurant Brands International Inc. reported net income of US$357 million for its third quarter, down from US$364 million in the same quarter last year.
The company, which keeps its books in U.S. dollars, says its profit amounted to 79 cents US per diluted share for the quarter ended Sept. 30 compared with 79 cents US per diluted share a year earlier.
Revenue for the parent company of Tim Hortons, Burger King, Popeyes and Firehouse Subs, totalled US$2.29 billion, up from US$1.84 billion in the same quarter last year.
Consolidated comparable sales were up 0.3 per cent.
On an adjusted basis, Restaurant Brands says it earned 93 cents US per diluted share in its latest quarter, up from an adjusted profit of 90 cents US per diluted share a year earlier.
The average analyst estimate had been for a profit of 95 cents US per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Nov. 5, 2024.
ST. JOHN’S, N.L. – Fortis Inc. reported a third-quarter profit of $420 million, up from $394 million in the same quarter last year.
The electric and gas utility says the profit amounted to 85 cents per share for the quarter ended Sept. 30, up from 81 cents per share a year earlier.
Fortis says the increase was driven by rate base growth across its utilities, and strong earnings in Arizona largely reflecting new customer rates at Tucson Electric Power.
Revenue in the quarter totalled $2.77 billion, up from $2.72 billion in the same quarter last year.
On an adjusted basis, Fortis says it earned 85 cents per share in its latest quarter, up from an adjusted profit of 84 cents per share in the third quarter of 2023.
The average analyst estimate had been for a profit of 82 cents per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Nov. 5, 2024.
TORONTO – Thomson Reuters reported its third-quarter profit fell compared with a year ago as its revenue rose eight per cent.
The company, which keeps its books in U.S. dollars, says it earned US$301 million or 67 cents US per diluted share for the quarter ended Sept. 30. The result compared with a profit of US$367 million or 80 cents US per diluted share in the same quarter a year earlier.
Revenue for the quarter totalled US$1.72 billion, up from US$1.59 billion a year earlier.
In its outlook, Thomson Reuters says it now expects organic revenue growth of 7.0 per cent for its full year, up from earlier expectations for growth of 6.5 per cent.
On an adjusted basis, Thomson Reuters says it earned 80 cents US per share in its latest quarter, down from an adjusted profit of 82 cents US per share in the same quarter last year.
The average analyst estimate had been for a profit of 76 cents US per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Nov. 5, 2024.
